Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase IIb |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | 2016-03-31 |
| Study Made Public: | NA |
Title
A Phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection among men and transgender persons who have sex with men
Description
HVTN 704/HPTN 085 (AMP study) is a Phase IIb clinical trial to evaluate the safety and immunogenicity of VRC-HIVMAB060-00-AB (VRC01 mAb).
Sign in to see full information about this study and to download study data.
Products
Saline (NaCl) VRC01Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.